Pleurodesis device and method

US9682218B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9682218-B2
Application numberUS-201314139008-A
CountryUS
Kind codeB2
Filing dateDec 23, 2013
Priority dateDec 23, 2013
Publication dateJun 20, 2017
Grant dateJun 20, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

System and components for inducing pleurodesis or other sclerosis or desired adhesion conditions to treat a patient, while minimizing likelihood of tissue damage from direct application of sclerosis-enhancing materials. A tube device is provided that is configured to elute sclerosis-enhancing material and/or other medicaments via a fenestrated drainage tube. The assembly of tube device with outer (typically drainage) tube may include one or more features configured to enhance delivery of medicament and/or drainage through the same assembly.

First claim

Opening claim text (preview).

We claim: 1. An injection catheter assembly comprising: an elongate flexible outer tube body including: a distal length configured to indwell a patient body trunk cavity; and at least one body lumen extending longitudinally through at least a lengthwise portion of the distal length, the body lumen substantially defined by an inner diameter surface of the outer tube body; wherein at least one portion of the distal length is configured as an injection portion that includes at least one outer tube body surface with at least one fenestration, the at least one fenestration including a first fenestration at a location distal of a sealing cuff on the outer tube body surface, the outer tube body surface constructed to permit passage therethrough of a sclerotic agent; and a flexible, curved inner cannula body dimensioned for passage through the body lumen of the outer tube body, the inner cannula body being fully removably insertable through the first fenestration into the body lumen of the outer tube body, the inner cannula body including: a memory-material portion imposing a pre-determined curve along a length of the inner cannula body; an injection lumen extending longitudinally through at least a lengthwise portion of the inner cannula body; at least one distal-region opening configured for dispensing a medicament; a first state where the distal-region opening of the inner cannula body is outside of the outer tube body; and a second state wherein the inner cannula body is disposed through the first fenestration at the location distal of the sealing cuff, into the body lumen, and through at least a lengthwise portion of the distal outer tube body length, so that: the distal region opening of the inner cannula body is within the outer tube body and is in fluid communication with the body lumen of the outer tube body, or a sufficient length of the inner cannula body extends distally from the first fenestration through the injection portion of the outer tube body such that the distal-region opening of the inner cannula body is disposed outside of the outer tube body. 2. The assembly of claim 1 , further comprising a port in fluid communication with the injection lumen. 3. The assembly of claim 1 , wherein the at least one fenestration is dimensioned to permit effective passage therethrough of a talc suspension. 4. The assembly of claim 1 , wherein the at least one body lumen of the outer tube body comprises a plurality of lumens. 5. The assembly of claim 1 , the inner cannula body further comprising at least one visualization marker configured to be visualizable in a patient body by at least one of fluoroscopy, ultrasound, magnetic resonance imaging, and computed tomography. 6. The assembly of claim 1 wherein the injection lumen of the inner cannula body is at least partially pre-filled with dispensable medicament. 7. The assembly of claim 6 , wherein the dispensable medicament comprises a sclerosing agent. 8. The assembly of claim 6 , wherein the dispensable medicament comprises a therapeutic agent. 9. The assembly of claim 6 , wherein the dispensable medicament comprises an effervescent material. 10. The assembly of claim 1 , where at least one of the inner cannula body and the outer tube body includes a lubricious coating configured to resist adhesion by a medicament. 11. The assembly of claim 1 , the inner cannula body further comprising a removable structure blocking fluid communication with a proximal opening of the injection lumen. 12. A method of delivering medicament via a catheter in a body lumen, the method comprising steps of: directing a distal portion of an assembly of claim 1 into a body lumen; later directing the at least one distal-region opening to a target site in the body lumen; and dispensing a medicament to the target site. 13. The method of claim 12 , wherein the injection lumen of the inner cannula body is at least partially pre-filled with dispensable medicament. 14. The method of claim 12 , wherein the dispensable medicament comprises a sclerosing agent. 15. The method of claim 12 , wherein the dispensable medicament comprises a therapeutic agent. 16. The method of claim 12 , wherein the dispensable medicament comprises an effervescent material. 17. The method of claim 12 , where at least one of the inner cannula body and the outer tube body includes a lubricious coating configured to resist adhesion by a medicament. 18. The method of claim 12 , the inner cannula body further comprising a removable structure blocking fluid communication with a proximal opening of the injection lumen. 19. The method of claim 12 , wherein the inner cannula body is disposed through at least a lengthwise portion of the distal outer tube body length during the directing step, and is extended to or beyond a distal end of the distal outer tube body length during the later directing step. 20. The assembly of claim 1 , wherein the first fenestration is configured to facilitate drainage from a body cavity when the inner cannula body is removed from the first fenestration.

Assignees

Inventors

Classifications

  • Markers, e.g. radio-opaque or breast lesions markers · CPC title

  • characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts · CPC title

  • Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube · CPC title

  • pre-formed, e.g. specially adapted to fit with the anatomy of body channels (urethral catheters A61F2/04) · CPC title

  • Radiopaque markers visible in an X-ray image · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9682218B2 cover?
System and components for inducing pleurodesis or other sclerosis or desired adhesion conditions to treat a patient, while minimizing likelihood of tissue damage from direct application of sclerosis-enhancing materials. A tube device is provided that is configured to elute sclerosis-enhancing material and/or other medicaments via a fenestrated drainage tube. The assembly of tube device with out…
Who is the assignee on this patent?
Carefusion 2200 Inc
What technology area does this patent fall under?
Primary CPC classification A61M25/0662. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).